You are here

Article Text

Article menu
Download PDFPDF
Miscellaneous
Does oestrogen lead to improved survival in women with non-small cell lung cancer?
  1. J Ostberg
  1. SpR, University College London Hospitals, London, UK; j.ostberg@ucl.ac.uk

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    ▴ Moore KA, Merry CM, Jaklitsch MT, et al. Menopausal effects on presentation, treatment, and survival of women with non-small cell lung cancer. Ann Thorac Surg2003;76:178–95
    OpenUrlCrossRef

    Previous reports have shown higher survival rates in women than in men with non-small cell lung cancer (NSCLC), and oestrogen receptors are expressed on human NSCLC cells. 14 676 women from the US 1992–1997 Surveillance, Epidemiology, and End Results database with primary NSCLC were categorised as premenopausal (age 31–50 years, n = 2230) or postmenopausal (51–70 years, n = 12 446), the average age of menopause being taken …

    View Full Text